98%
921
2 minutes
20
Objective: The Rules of 6 (flow volume >600 mL/min, vein diameter >6 mm, vein depth <6 mm) are widely used to determine when an arteriovenous fistula (AVF) will support dialysis. Thus, we tested the utility of the Rules of 6 in clinical practice.
Methods: We retrospectively reviewed AVFs created at a single center from 2016 to 2019 for patients who had undergone dialysis within the same healthcare system. Clinical records and postoperative ultrasound studies were reviewed for the Rules of 6 criteria. Maturation was defined as use of the AVF with two needles for 75% of the dialysis sessions for a continuous 4-week period, with a mean flow of 300 mL/min or urea clearance (Kt/V) of 1.2. Predictors of maturation were assessed using logistic regression and receiver operating characteristic (ROC) curves.
Results: Five surgeons performed 202 AVFs of three types during 2016 to 2019 (radial-cephalic, n = 49; brachial-cephalic, n = 87; brachial-basilic, n = 66). Maturation occurred in 150 AVFs (74%; primary, n = 101 [50%]; assisted, n = 49 [24%]), while 52 (26%) failed to mature. Maturation did not vary by AVF type or patient sex or diabetes status. A higher body mass index was associated with failure to mature (P = .004). Only 16 mature AVFs (11%) met all three Rules of 6 using mean values for flow, diameter, and depth. However, 101 (67%) met all three Rules using the extreme, maximum or minimum, values. On multivariate analysis, each Rule of 6 was independently associated with maturation. If all three Rules were met, the AVF was nearly 10-fold more likely to have matured compared with an AVF satisfying no Rule. The body mass index correlated strongly with the vein depth (P < .001); however, both characteristics independently predicted maturation. The chance of maturation was highest if flow and depth Rules were met (positive predictive value [PPV], 93%); if all three rules were met, the PPV was 92%. The ROC area under curve (AUC) values for meeting flow volume and vein depth Rules together were higher than if all three Rules had been satisfied (0.784 vs 0.754). The PPV for diameter alone (78%) was the lowest of all PPVs for the three Rules and the ROC-AUC was only 0.588. If all three Rules together were not satisfied using extreme values, the negative predictive value was only 47%.
Conclusions: The Rules of 6 predict AVF maturation, especially when using extreme, maximum or minimum, values to satisfy each Rule. Flow volume and vein depth together predict maturation equally as well as meeting all three Rules. Vein diameter seems less important. The Rules of 6 might be too stringent if used exclusively to predict for functional AVF maturation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvs.2022.02.018 | DOI Listing |
Cancer Med
September 2025
Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Background: Patients with clear cell renal cell carcinoma (ccRCC) often undergo organ resection, with treatment strategies based on recurrence risk. Current metastatic potential assessments rely on the WHO/ISUP grading system, which is subject to interobserver variability.
Methods: We developed an artificial intelligence (AI) model to classify cells according to contemporary grading rules and evaluated the prognostic significance of tumor cell profiles, particularly focusing on cells with prominent nucleoli.
mBio
September 2025
Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.
Accurate timing estimates of when participants acquire HIV in HIV prevention trials are necessary for determining antibody levels at acquisition. The Antibody-Mediated Prevention (AMP) Studies showed that a passively administered broadly neutralizing antibody can prevent the acquisition of HIV from a neutralization-sensitive virus. We developed a pipeline for estimating the date of detectable HIV acquisition (DDA) in AMP Study participants using diagnostic and viral sequence data.
View Article and Find Full Text PDFJ Nephrol
September 2025
Nephrology and Dialysis Unit, ASL Nord Ovest Toscana, Livorno, Italy.
Hypertension is a clinical condition associated with an increase in cardiovascular morbidity and mortality. In chronic kidney disease (CKD), hypertension is also a driver of faster disease progression. Correct and appropriate treatment with antihypertensive medication reduces the risk of cardiovascular events and slows kidney disease progression.
View Article and Find Full Text PDFCureus
August 2025
Norton College of Medicine, SUNY Upstate Medical University, Syracuse, USA.
Hydralazine is an antihypertensive that can induce immune-related adverse effects, such as hydralazine-induced lupus and hydralazine-induced antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV). AAV involves necrotizing inflammation of small blood vessels, manifesting as fever, malaise, arthralgia, and myalgia, potentially leading to organ failure. Diagnosis includes clinical evaluation, serological testing for ANCA, and histopathological examination, confirmed by necrotizing granulomatous inflammation in affected tissues.
View Article and Find Full Text PDFJ Multidiscip Healthc
September 2025
School of Law, Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.
The application of generative artificial intelligence (AI) technology in the healthcare sector can significantly enhance the efficiency of China's healthcare services. However, risks persist in terms of accuracy, transparency, data privacy, ethics, and bias. These risks are manifested in three key areas: first, the potential erosion of human agency; second, issues of fairness and justice; and third, questions of liability and responsibility.
View Article and Find Full Text PDF